Studies from Jiangsu University Have Provided New Information about Phage Libraries (Discovery of an Heparin-binding Epidermal Growth Factor Domain Antibody From a Phage Library and Analysis of Its Inhibitory Effects In Skov3 Cells).

Researchers from Jiangsu University in China have discovered a humanized antibody that targets heparin-binding epidermal growth factor (HB-EGF), a protein associated with inflammation and the progression of ovarian cancer. The antibody was found using phage display technology and was shown to inhibit the functions of HB-EGF in promoting invasion and migration of ovarian cancer cells. This discovery has the potential to lead to the development of novel drugs or therapies for ovarian cancer treatment. The research has been peer-reviewed and published in Cancer Biotherapy & Radiopharmaceuticals. [Extracted from the article]

Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)